Literature DB >> 25752545

Bevacizumab and quality of life in advanced cervical cancer.

David Cella1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25752545     DOI： 10.1016/S1470-2045(15)70052-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Design Issues in Randomized Clinical Trials of Maintenance Therapies.

Authors:  Boris Freidlin; Richard F Little; Edward L Korn
Journal:  J Natl Cancer Inst       Date:  2015-08-18       Impact factor: 13.506

2.  Dysphagia as a Rare Presentation of Cervical Cancer with Mediastinal Metastasis.

Authors:  Vinit Singh; Dhairya Gor; Sarah Azad; Anthony Ricca; Yiqing Xu; Trishala Meghal
Journal:  Eur J Case Rep Intern Med       Date:  2022-01-24

Review 3.  Profile of bevacizumab and its potential in the treatment of cervical cancer.

Authors:  Christine M Fisher; Tracey E Schefter
Journal:  Onco Targets Ther       Date:  2015-11-19       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.